Markets:

Overview

News

Currencies

International

Treasuries

CorMedix Inc. - Common Stock (NQ:CRMD)

9.680 -0.040 (-0.41%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CorMedix Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 29, 2023

Via Benzinga

Why Shares of CorMedix Are Slumping Thursday ↗

June 29, 2023

The company announced a stock sale and the sale of prefunded warrants.

Via The Motley Fool

Why Are Bank Stocks WFC, JPM, BAC Up Today? ↗

June 29, 2023

Banks stocks are heading higher on Thursday as investors react to the positive results of a stress test from the Federal Reserve.

Via InvestorPlace

FREY Stock Price Prediction: Is Freyr Battery Really Worth $13? ↗

June 29, 2023

Freyr Battery (FREY) stock is on the move Thursday with heavy trading following positive coverage from analysts at Morgan Stanley.

Via InvestorPlace

Why Is Cormedix (CRMD) Stock Down 23% Today? ↗

June 29, 2023

Cormedix (CRMD) stock is falling hard on Thursday with heavy trading after the company priced a public offering of its shares.

Via InvestorPlace

Why Cormedix (CRMD) Stock Is Getting Hammered ↗

June 29, 2023

CorMedix Inc. (NASDAQ: CRMD) shares are trading lower by 23.27% to $3.89 Thursday morning after the company priced its public offering of 7.5 million shares at $4 per share and pre-funded warrants to...

Via Benzinga

Analyst Ratings for Cormedix ↗

June 21, 2023

Analysts have provided the following ratings for Cormedix (NASDAQ:CRMD) within the last quarter:

Via Benzinga

What 5 Analyst Ratings Have To Say About Cormedix ↗

May 16, 2023

Via Benzinga

CorMedix (CRMD) Q1 2023 Earnings Call Transcript ↗

May 15, 2023

CRMD earnings call for the period ending March 31, 2023.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 29, 2023

Via Benzinga

Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket ↗

June 29, 2023

Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 29, 2023

We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today!

Via InvestorPlace

Recap: Cormedix Q1 Earnings ↗

May 15, 2023

Via Benzinga

Preview: Cormedix's Earnings ↗

May 12, 2023

Via Benzinga

Expert Ratings for Cormedix ↗

March 31, 2023

Via Benzinga

Cormedix's Return On Capital Employed Overview ↗

March 31, 2023

Via Benzinga

A Preview Of Cormedix's Earnings ↗

March 29, 2023

Via Benzinga

As CorMedix's DefenCath Moves Forward On Regulatory Path, Analyst Boosts Price Target ↗

May 19, 2023

Tuesday, CorMedix Inc (NASDAQ: CRMD) resubmitted New Drug Application for DefenCath to the FDA, and the submission has been acknowledged as

Via Benzinga

Citius Pharmaceuticals Approaches End Of Trial For Catheter-Related Bloodstream Infections – How Are Analysts Scoring Its Stock? ↗

May 04, 2023

The late-stage biopharma Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is approaching the conclusion of the phase 3 trial for its drug, Mino-Lok.

Via Benzinga

7 Small-Cap Biotech Stocks with Massive Potential ↗

April 27, 2023

Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.

Via InvestorPlace

7 Biotech Stocks With Huge Return Potential for Long-Term Investors ↗

April 26, 2023

Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers.

Via InvestorPlace

Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow ↗

April 11, 2023

A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global...

Via Benzinga

Cormedix's Return On Capital Employed Insights ↗

December 20, 2022

Via Benzinga

Recap: Cormedix Q2 Earnings ↗

August 11, 2022

Cormedix (NASDAQ:CRMD) reported its Q2 earnings results on Thursday, August 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

CorMedix Inc Common Stock (CRMD) Q3 2022 Earnings Call Transcript ↗

November 10, 2022

CRMD earnings call for the period ending September 30, 2022.

Via The Motley Fool

CorMedix Inc. (NASDAQ:CRMD) Shareholder Alert: Investigation over Potential Wrongdoing ↗

November 04, 2022

San Diego, CA -- (SBWIRE) -- 11/04/2022 -- Certain directors of CorMedix Inc. are under investigation over potential breaches of fiduciary duties.

Via SBWire

CorMedix Inc. (NASDAQ:CRMD) Shareholder Notice: Update in Lawsuit Announced ↗

September 21, 2022

San Diego, CA -- (SBWIRE) -- 09/21/2022 -- An update was announced in the lawsuit that is pending for certain investors in shares of CorMedix Inc. (NASDAQ:CRMD).

Via SBWire

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know ↗

August 31, 2022

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

Via Benzinga

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,100 Today ↗

August 16, 2022

Cormedix (NASDAQ:CRMD) has outperformed the market over the past 10 years by 2.86% on an annualized basis producing an average annual return of 14.54%. Currently, Cormedix has a market capitalization...

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

CorMedix Inc. - Common Stock (NQ:CRMD)

All News about CorMedix Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today